NEXGEL, INC.
NXGL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
Other share classesNXGLW
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
19
- +1 vs. Q1 2026
- Total value $292.96K
Superinvestors holding NXGL
0
- None of the superinvestors held NXGL at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by NXGL insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 18 – Jun 23, 2026 | Levy Adam R.Chief Executive Officer | SSaleCommon Stock | −11K | $0.59 | −$6.49K | 322.69K | −3.3% | SEC |
| Jun 15, 2026 | Jun 11, 2026 | Levy Adam R.Chief Executive Officer | SSaleCommon Stock | −3K | $0.61 | −$1.83K | 333.69K | −0.9% | SEC |
| Jun 9, 2026 | Jun 4 – Jun 8, 2026 | Levy Adam R.Chief Executive Officer | SSaleCommon Stock | −6K | $0.57 | −$3.42K | 336.69K | −1.8% | SEC |
| Jun 3, 2026 | Jun 1, 2026 | Levy Adam R.Chief Executive Officer | SSaleCommon Stock | −2K | $0.59 | −$1.18K | 342.69K | −0.6% | SEC |
| May 29, 2026 | May 27 – May 29, 2026 | Levy Adam R.Chief Executive Officer | SSaleCommon Stock | −13K | $0.6054 | −$7.87K | 344.69K | −3.6% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in NXGL at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 85,140 | $42.66K | 0.00% | +85,140 | New |
| Virtu Financial LLC | 79,128 | $40K | 0.00% | +79,128 | New |
| GEODE CAPITAL MANAGEMENT, LLC | 71,863 | $36.01K | 0.00% | −56,673−44.1% | Reduced |
| HRT FINANCIAL LP | 69,485 | $34K | 0.00% | +53,989+348.4% | Added |
| MORGAN STANLEY | 54,980 | $27.55K | 0.00% | 00.0% | Unchanged |